Today

FuelCell Energy announces a mixed offering of 34.5M common shares at $6.50/share, including 19.8M primary shares and 14.7M resale shares, discounted from its recent market price.

Nuvve Holding Corp. registered 42.4 million shares of common stock for resale by selling stockholders, representing a significant overhang on the current shares outstanding.

GoPro filed an S-1/A amendment for the resale of up to 120 million Class A common shares by a selling stockholder, potentially diluting existing shareholders by over 80%.

GoPro has registered up to 120 million Class A common shares for resale by YA II PN, Ltd., which could significantly dilute existing shareholders and increase market supply.

Direct Digital Holdings filed an S-1/A to register up to 20 million shares for resale by Roth Principal Investments, representing significant potential dilution.

FibroBiologics has registered 41.3 million common shares for resale by YA II PN, Ltd. (Yorkville) via a standby equity purchase agreement, representing significant potential dilution.

Immunic registers a massive 458.15M shares for resale by selling stockholders, a potential 46x overhang, derived from pre-funded and common warrants. The company will not receive proceeds from resales but may get cash from warrant exercises. A pending reverse stock split will adjust the share count, but the dilution risk remains severe.

PodcastOne filed a universal shelf registration for $150 million, significantly exceeding its current market cap, creating future dilution potential.

AVAX One filed a $2.0B universal shelf registration, allowing future sales of various securities. This huge capacity is 48x its market cap, signaling substantial potential dilution.

RenX Enterprises registered 63.05M shares for resale by selling stockholders, primarily from convertible notes and warrants, posing significant potential dilution for existing shareholders.

MicroVision registers 61.3M shares for resale by selling holders, which could lead to significant dilution and market overhang.

Tempest Therapeutics filed to register 2.78 million shares for resale by existing stockholders, including shares underlying warrants, which could represent significant future dilution.

Brenmiller Energy registered 5.9 million shares for resale by a selling shareholder, including ordinary shares underlying convertible preferred stock and warrants, which could lead to significant dilution and share price pressure if these securities are converted and sold.

Diana (DSX) increased its all-cash offer for Genco (GNK) to $24.80 per share and extended the tender offer deadline to June 26, 2026.

IceCure Medical is conducting a registered direct offering of 8 million ordinary shares at $0.50 per share, bundled with two series of warrants (Series B and Series C) to purchase an additional 16 million ordinary shares in a concurrent private placement. The warrants have an exercise price of $0.55 per share.

Sangamo Therapeutics priced a public offering for $23.3 million, selling common stock and pre-funded warrants alongside new purchase warrants, resulting in significant potential dilution.

VCI Global registers up to 69.9 million ordinary shares for resale by Alumni Capital LP, arising from convertible notes and warrants, signaling significant potential dilution.

ADS-TEC Energy is raising $50 million through senior secured convertible notes and warrants, introducing significant potential dilution due to variable conversion prices and warrant exercises.

GCT Semiconductor is raising up to $19.3 million through the sale of $20 million in convertible notes to Obsidian Global, with conversion into common stock at a variable 5% discount to VWAP.

SCYNEXIS registers up to 87 million shares for resale by selling stockholders, including common and pre-funded warrant shares, from a recent private placement.